The Competition Commission of Pakistan (CCP) has issued show-cause notices to four companies for prima facie violation of Section 10 of the Competition
The CCP’s inquiry concluded that the marketing campaign of the respondent appears to be deceptive in terms of Section 10 of the Competition Act. AFP/File
ISLAMABAD: The Competition Commission of Pakistan (CCP) on Thursday imposed a Rs150 million penalty on a pharmaceutical company for deceptive marketing and misleading advertising of one of its products.
The order, passed by a CCP bench comprising chairperson Rahat Kaunain Hassan and member Bushra Naz Malik, said that marketing claims by the pharmaceutical firm can potentially deceive consumers with respect to the characteristics, formulation and intended use of tablet Strepsils.